Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 5 (2008), Issue 1 (January)

1. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis.
   Gastroenterology, 134(1): 248-58. [Abstract] [Full-text]
2. Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis.
   Gastroenterology, 134(1): 111-9. [Abstract] [Full-text]
3. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography.
   Gastroenterology, 134(1): 8-14. [Abstract] [Full-text]
4. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
   Gastroenterology, 134(1): 102-10. [Abstract] [Full-text]
5. Human parathyroid hormone 1-34 prevents bone loss in experimental biliary cirrhosis in rats.
   Gastroenterology, 134(1): 259-67. [Abstract] [Full-text]
6. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.
   JAMA, 299(1): 53-60. [Abstract] [Full-text]
7. Impaired indoleamine 2,3-dioxygenase production contributes to the development of autoimmunity in primary biliary cirrhosis.
   Autoimmunity, 41(1): 92-9. [Abstract] [Full-text]
8. VH gene usage and CDR3 analysis of B cell receptor in the peripheral blood of patients with PBC.
   Autoimmunity, 41(1): 80-6. [Abstract] [Full-text]
9. UDP-glucuronosyltransferase 1A7 polymorphisms are associated with liver cirrhosis.
   Biochem Biophys Res Commun, 366(3): 643-8. [Abstract] [Full-text]
10. Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis.
    Joint Bone Spine, 75(1): 87-9. [Abstract] [Full-text]
11. Cardiovascular complications of cirrhosis.
    Gut, 57(2): 268-78. [Abstract] [Full-text]
12. Exercise performance and ventilatory efficiency in patients with mild and moderate liver cirrhosis.
    Clin Exp Pharmacol Physiol, 35(2): 135-40. [Abstract] [Full-text]
13. Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats.
    Clin Exp Pharmacol Physiol, 35(2): 159-67. [Abstract] [Full-text]
14. Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis.
    J Virol, 82(3): 1259-70. [Abstract] [Full-text]
15. Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells.
    Biochem Biophys Res Commun, 367(1): 116-23. [Abstract] [Full-text]
16. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation.
    Mol Pharmacol, 73(2): 399-409. [Abstract] [Full-text]
17. Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.
    J Pharmacol Exp Ther, 324(2): 475-83. [Abstract] [Full-text]
18. Cutaneous sarcoidosis and primary biliary cirrhosis: A chance association or related diseases?
    J Am Acad Dermatol, 58(2): 326-35. [Abstract] [Full-text]
19. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis.
    Aliment Pharmacol Ther, 27(5): 441-7. [Abstract] [Full-text]
20. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.
    J Viral Hepat, 15(3): 165-72. [Abstract] [Full-text]
21. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    J Viral Hepat, 15(3): 212-8. [Abstract] [Full-text]

© 2004-2010 Liver Cirrhosis Research Today. All Rights Reserved.